Please login to the form below

Not currently logged in
Email:
Password:

Aelix Therapeutics

This page shows the latest Aelix Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • Gilead and Aelix join forces to pursue HIV ‘cure’ Gilead and Aelix join forces to pursue HIV ‘cure’

    Gilead Sciences – already a giant in HIV therapy – has teamed up with Spanish biotech Aelix Therapeutics to try to develop a treatment regimen that would go beyond controlling the virus and ... Gilead is planning human trials of vesatolimod with an

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    He said: “Aelix Therapeutics has reached a crucial milestone by enrolling the first patient in the phase I clinical trial and I’m thrilled to be joining the company at this ... in the pharmaceutical industry will be of great value to the future of

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics